<DOC>
	<DOCNO>NCT01654783</DOCNO>
	<brief_summary>The objective study investigate oral 5-ASA drug use condition without symptom abdominal pain diarrhea/bloody stool ( remission stage ) , transition condition symptom abdominal pain diarrhea/bloody stool ( active stage ) remission stage ulcerative colitis study many patient able maintain remission stage observation period many time patient experience active stage ( relapse ) , well symptom change observation period discover good treatment plan .</brief_summary>
	<brief_title>Observational Study Management Ulcerative Colitis With Oral 5-ASA</brief_title>
	<detailed_description>Period : 2012-2014 Observation Time : 0 , 26week , 52week Matters investigate : 1. pUCDAI score ( Stool frequency , Bloody stool , Physician 's global assessment ) 2 . Medication adherence ( VAS scale ) 3 . Remission , Relapse 4 . Age , gender , body height , body weight , date diagnosis , extension inflammation , classification clinical course , smoking , alcohol , work , disease complication , duration remission maintain enrollment ( remission patient )</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<criteria>1 . Outpatients 2 . Adult patient diagnose mild moderate active ulcerative colitis ulcerative colitis remission stage accord diagnostic criterion ulcerative colitis ( draft revise February 13 , 2010 ) 3 . Patients treated remission induction therapy remission maintenance therapy oral 5ASA drug ( Pentasa速 tablets 250 mg , Pentasa速 tablets 500 mg , Asacol速 tablets 400 mg Salazopyrin速 tablets 500 mg well drug prove equivalent drug ) 4 . Patients receive adequate information regard study understood thoroughly , voluntarily submit write consent form upon participation study 1 . Patients severe active ulcerative / fulminant ulcerative colitis accord diagnostic criterion ulcerative colitis ( draft revise February 13 , 2012 ) 2 . Patients receive total / subtotal colectomy 3 . Patients complicate malignant tumor 4 . Patients pregnant possibly pregnant 5 . Other patient investigator subinvestigators consider inappropriate participate study</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>5-ASA , ulcerative colitis , active , remission , adherence</keyword>
</DOC>